Huajian Medical and Renhe International reach cooperation to jointly build a vertical RWA trading platform focused on the over-the-counter drug sector
Jinse Finance reported that Huajian Medical, a Hong Kong-listed company, has issued an announcement stating that the group has reached a strategic cooperation with Renhe International, a wholly-owned subsidiary of Renhe Pharmaceutical Co., Ltd. Together, they will jointly establish a vertical RWA trading platform in the United States focused on the over-the-counter drug sector. (Zhitong Finance)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Uniswap App now supports purchasing cryptocurrencies using Revolut balance
AZTEC token public sale is now live, with subscription amount exceeding 15,900 ETH.
Cicada Tech and Linkage Global announce the signing of a non-binding merger and acquisition letter of intent
